Quick Answer
CalciMedica, Inc. reported Total Assets of $13.59 million for the year ending 2025.
- CalciMedica, Inc. showed a decrease of -31.3% in Total Assets from 2024 to 2025.
- This data is from CalciMedica, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $98.39 million | Q1 2021: $90.85 million | Q2 2021: $82.82 million | Q3 2021: $76.64 million | Q1 2022: $60.59 million | Q2 2022: $54.02 million | Q3 2022: $45.36 million | Q1 2023: $34.67 million | Q2 2023: $20.25 million | Q3 2023: $15.85 million | Q1 2024: $27.13 million | Q2 2024: $21.05 million | Q3 2024: $16.21 million | Q1 2025: $25.35 million | Q2 2025: $19.08 million | Q3 2025: $14.91 million.
- Over the full 7 years of available data (2019 to 2025), CalciMedica, Inc.'s Total Assets has declined by 66.6%.
- Historical annual values: Fiscal year 2025: $13.59 million | Fiscal year 2024: $19.79 million | Fiscal year 2023: $12.19 million | Fiscal year 2022: $3.35 million | Fiscal year 2021: $69.09 million | Fiscal year 2020: $101.79 million | Fiscal year 2019: $40.66 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: